Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Fulvestrant is a potent estrogen receptor (ER) antagonist that works by down-regulating and degrading the estrogen receptor, ERα.1 The prescription drug, Faslodex®, is efficacious in the treatment of estrogen-sensitive breast cancer, in part because it largely lacks agonist activity in relevant tissues.2 However, fulvestrant was found to fully activate ER on rat hippocampal neurons,3 suggesting it might afford protective neurological benefits with aging.
1
Kansra, S., Yamagata, S., Sneade, L., et al. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol23927-36(2005).
2
Addo, S., Yates, R.A., and Laight, A. A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers. Br J Cancer871354-1359(2002).
3
Zhao, L., O'Neill, K., and Brinton, R.D. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: Implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther319(3)1124-1132(2006).
Kansra, S., Yamagata, S., Sneade, L., et al. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol23927-36(2005).
Addo, S., Yates, R.A., and Laight, A. A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers. Br J Cancer871354-1359(2002).
Zhao, L., O'Neill, K., and Brinton, R.D. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: Implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther319(3)1124-1132(2006).
Size
Price
Quantity
Subtotal
1 mg
$15.00
$0.00
5 mg
$68.00
$0.00
10 mg
$120.00
$0.00
50 mg
$525.00
$0.00
Bulk
Contact
Cart Total
$0.00
This product is available in custom sizes and/or larger quantities.